A detailed history of Rollins Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rollins Financial Advisors, LLC holds 1,693 shares of LLY stock, worth $1.53 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,693
Previous 1,810 6.46%
Holding current value
$1.53 Million
Previous $1.41 Billion 8.87%
% of portfolio
0.26%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $84,809 - $106,357
-117 Reduced 6.46%
1,693 $1.53 Billion
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $608,781 - $814,463
1,028 Added 131.46%
1,810 $1.41 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $410,698 - $484,159
782 New
782 $456 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rollins Financial Advisors, LLC Portfolio

Follow Rollins Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rollins Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rollins Financial Advisors, LLC with notifications on news.